Data di Pubblicazione:
2016
Abstract:
The alternative splicing (AS) mechanism is considered the major driving force of transcriptome and
proteome diversity. Itrelies on a delicate and finely tuned interplay among a great number of molecular
elements. The crucial action of AS in the regulation of diverse biological processes is not limited to
physiological states, but is mirrored in the growing list of human diseases associated with known or suspected
splicing defects, including neurodegenerative and oncologicaldiseases. In these pathologies, the AS regulation
of PARK2gene (also called parkin RBR E3 ubiquitin protein ligase), one of the largest in our genome, seems to
play a fundamental role. Here, we will briefly review some major data concerning the genetic organization, the
transcription regulation, the structure of the protein and the relative molecular functions of PARK2. Then we
will focuson the current knowledge about PARK2 alternative spliced isoforms and their implication in human
diseases
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
PARK2; parkin; alternative splicing; Parkinson's disease; cancer
Elenco autori:
LA COGNATA, Valentina; Cavallaro, Sebastiano; Cavalcanti, Francesca
Link alla scheda completa:
Pubblicato in: